Resectable Non-small Cell Lung Cancer

DBCOND0068626NeoplasmsRespiratory Tract Diseases

Resectable Non-small Cell Lung Cancer is the indication for 4 drugs in DrugBank. It is covered by 15 curated, structured indications.

Also known as
Resectable Non-Small-Cell Lung Cancer
Classified under
Indicated drugs

Resolves to

Vocabularies
SNOMED CT254637007MedDRA10029514UMLSC0007131

What you can answer from here — as of October 22, 2026

4Indicated drugsWith each drug's targets and mechanism
Listed above
15Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
15Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Drug reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Resectable Non-small Cell Lung Cancer share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In